search

callahantiff / PheKnowVec

Translational Computational Phenotyping
2 stars 0 forks source link

Project Meeting -- 05/25/2019 @ 12:00 #90

Closed callahantiff closed 5 years ago

callahantiff commented 5 years ago

Meeting Date: 05/25/2019 @ 12pm Topic: Code Set Verification Task Training Attendees: @jwyrwa @emswen @kandrews11

Proposed Agenda for Wednesday's Training:

callahantiff commented 5 years ago

Hey Team aka @jwyrwa @emswen @kandrews11 -

Thanks for a great meeting today! 👏 🎉 😃

As discussed, the plan going forward is to have @emswen and @kandrews11 work on the Appendicitis_Conditions files first. Once completed, we will have a check-in to make sure that everything went smoothly and that no changes are needed. Gals, let me know once you have completed this file by writing me a comment in that phenotype's issue.

If you have any questions, don't hesitate to reach out!

jwyrwa commented 5 years ago

@emswen @kandrews11 feel free to utilize me as a resource too, either via text/call/GitHub/smoke signals.

callahantiff commented 5 years ago

Hey guys! Just an update...

Thanks to a great suggestion by @emswen and @kandrews11 I have added 3 new categories to the selection choices. These choices are meant to be used when you are verifying the mappings for control patients. You can tell which codes may be used for control patients here. Please note that it is possible that the same exclusionary criteria be used for both cases and controls, thus these new categories should only be used when the criteria applies only to control patients .

These new options were added because the prior categories did not easily account for control patients in the sense that we can't possible know all the criteria that are used when selecting control patients, like we can with cases. Thus, there are scenarios where it would be very difficult to judge the clinical relevancy of a mapping.

I hope these are helpful, please let me know if you have any questions!

callahantiff commented 5 years ago

Closing this issue, please re-open if you have any additional questions.